[Vasoprotective Effects of Prolonged Therapy With Perindopril A in Patients with Hypertension Including Concomitant Type 2 Diabetes Mellitus].


Journal

Kardiologiia
ISSN: 0022-9040
Titre abrégé: Kardiologiia
Pays: Russia (Federation)
ID NLM: 0376351

Informations de publication

Date de publication:
04 Feb 2020
Historique:
received: 15 10 2019
accepted: 20 11 2019
entrez: 5 4 2020
pubmed: 5 4 2020
medline: 13 5 2020
Statut: epublish

Résumé

Objective Investigate the dynamics of morphological and functional markers of vascular remodeling in patients with arterial hypertension (AH), including those with concomitant type 2 diabetes mellitus (DM2), during 12-month administration of perindopril A.Material and Methods The study included patients with grade I-II AH, with and without DM2 (30 and 32 patients, respectively), who underwent outpatient correction of initially ineffective antihypertensive therapy and administration of perindopril A, 10 mg/day. Morphological and functional parameters of vascular remodeling were evaluated in all patients at baseline and at 12 months using photoplethysmography. Stiffness index (SI) and phase shift (PS) were measured in large vessels. Reflection index (RI) and occlusion index (OI) were measured in microvessels. Computed nailfold videocapillaroscopy was used to determine capillary density (CD) at rest (CDr), CD during venous occlusion test (CDvo), and CD during reactive hyperemia test (CDrh). Data are medians [interquartile range].Results After 12-month administration of perindopril A, the morphological and functional parameters of vascular remodeling in AH patients without DM2 significantly improved at all vascular levels. SI decreased to 9.25 [7.8; 10.93 ] m/s and PS increased to 7.4 [5.6; 9.05] ms. In microvasculature, a statistically significant reduction was observed in RI, 31 [27; 36.5]%, and an increase was observed in OI, which characterizes endothelium function, 1.75 [1.68; 1.9]. Capillary CDr significantly increased to 40.5 [34.93; 46] cap/mm2, as did CDvo and CDrh. At the same time, in the group of patients with AH and DM2, a significant improvement was observed for the large vessels. SI decreased to 9.8 [9.08; 10.58] m/s, and PS increased to 6.95 [5.13; 10.08]. The RI index, reflecting the structural condition of arterioles, significantly decreased to 34 [25.9; 45.53]%, and the OI index, characterizing endothelial function, did not change significantly, 1.4 [1.3; 1.6]. Capillary CDr significantly increased to 31.55 [27.68; 34.7 ] cap/mm2; however, CDvo and CDrh did not change significantly. Renal function improved in both groups.Conclusion Both groups demonstrated improvement of morphological parameters at all levels of the arterial bed. However, patients with AH and concomitant DM2 showed no improvement of the endothelial function of arterioles and capillaries compared to improvement in AH patients without DM2. This reflected the more severe endothelial dysfunction present in AH patients with DM2.

Identifiants

pubmed: 32245348
doi: 10.18087/cardio.2020.1.n888
doi:

Substances chimiques

Perindopril Y5GMK36KGY

Types de publication

Journal Article

Langues

rus

Sous-ensembles de citation

IM

Pagination

4-9

Auteurs

Yu A Danilogorskaya (YA)

I.M. Sechenov First Moscow State Medical University, Department of Hospital Therapy #1.

E A Zheleznykh (EA)

I.M. Sechenov First Moscow State Medical University, Department of Hospital Therapy #1.

E A Privalova (EA)

I.M. Sechenov First Moscow State Medical University, Department of Hospital Therapy #1.

Yu N Belenkov (YN)

I.M. Sechenov First Moscow State Medical University, Department of Hospital Therapy #1.

A A Shchendrigina (AA)

I.M. Sechenov First Moscow State Medical University, Department of Hospital Therapy #1.

M V Kozhevnikova (MV)

I.M. Sechenov First Moscow State Medical University, Department of Hospital Therapy #1.

G A Shakaryants (GA)

I.M. Sechenov First Moscow State Medical University, Department of Hospital Therapy #1.

V Yu Zektser (VY)

I.M. Sechenov First Moscow State Medical University, Department of Hospital Therapy #1.

A S Lishuta (AS)

I.M. Sechenov First Moscow State Medical University, Department of Hospital Therapy #1.

N V Khabarova (NV)

I.M. Sechenov First Moscow State Medical University, Department of Hospital Therapy #1.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH